[Comment] The US experiments with international reference pricing for prescription drugs

Summary

The article discusses US implementation of international reference pricing for prescription drugs under the Trump administration, with the aim to benchmark Medicare Part B drug prices to international levels, addressing concerns about US pharmaceutical prices being 3-5 times higher than European countries.